Dyadic’s research teams have the proven ability to bring biological products to market in minimal time. This is largely due to the pairing of strain and fermentation development processes, so that information from one naturally leads to improvements in the other. When combined with the use of hyper-producing C1 strains possessing excellent promoters, expression cassettes, and transformation techniques, these processes contribute to economically viable levels of protein production achieved in a short time.

The success of this approach is evident in Dyadic’s first major research program – the discovery and development of neutral cellulases in Chrysosporium lucknowense, or C1. Within one year, the wild strain of fungus discovered in the soil of eastern Russia was brought to commercial reality by Dyadic researchers. This achievement was followed by another significant advance when the same researchers tripled C1’s enzyme levels the next year.

It is this integrated approach to discovery and innovation that gives Dyadic the edge to develop groundbreaking new products from the earth’s vast gene pool, bringing nature to the marketplace.

Please visit Partnering Opportunities to find out how Dyadic can work with you to break the bottlenecks in your genomic research and development programs.